Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nivolumab induced radiation recall pneumonitis after two years of radiotherapy.

Literature DB >> 28383674

Nivolumab induced radiation recall pneumonitis after two years of radiotherapy.

R Shibaki¹, H Akamatsu¹, M Fujimoto², Y Koh¹, N Yamamoto¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28383674 DOI： 10.1093/annonc/mdx115

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

29 in total

Review 1. Radiation-Induced Lung Injury: Assessment and Management.

Authors: Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig
Journal: Chest Date: 2019-04-15 Impact factor: 9.410

2. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.

Authors: Tomomi W Nobashi; Yuko Nishimoto; Yujiro Kawata; Hidetaka Yutani; Masaki Nakamura; Yuichi Tsuji; Atsushi Yoshida; Akihiko Sugimoto; Takayuki Yamamoto; Israt S Alam; Satoshi Noma
Journal: Br J Radiol Date: 2020-08-12 Impact factor: 3.039

Review 3. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies.

Authors: Elizabeth Guimond; Chiaojung Jillian Tsai; Ali Hosni; Grainne O'Kane; Jonathan Yang; Aisling Barry
Journal: Adv Radiat Oncol Date: 2022-07-14

Nivolumab induced radiation recall pneumonitis after two years of radiotherapy.

Review 1. Radiation-Induced Lung Injury: Assessment and Management.

2. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.

Review 3. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies.

Review 4. PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer.

Review 5. The influence of radiation in the context of developing combination immunotherapies in cancer.

Review 6. Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety.

Review 7. Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: "MTD" or "ALARA"?

Review 8. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity.

Review 9. Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

10. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.